华夏恒生生物科技ETF发起式联接(QDII)A(016970)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
3,322,836.14 |
1,566,845.11 |
786,852.01 |
647,032.00 |
| 存出保证金 |
3,923,424.27 |
904,277.23 |
310,733.22 |
164,780.58 |
| 交易性金融资产 |
1,305,658,383.50 |
1,640,079,609.74 |
1,120,020,478.13 |
568,246,350.94 |
| 其中：股票投资 |
9,968.00 |
- |
- |
7,600,225.15 |
| 债券投资 |
27,203,084.66 |
60,616,372.61 |
30,164,706.85 |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
26,657,808.05 |
4,376,933.64 |
4,107,012.21 |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
13,366,806.65 |
24,312,428.74 |
33,993,391.68 |
6,695,125.72 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
1,409,356,218.61 |
1,749,996,099.09 |
1,212,723,229.04 |
613,167,400.69 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
- |
- |
1,374,152.16 |
| 应付赎回款 |
41,943,738.73 |
85,580,383.33 |
65,292,861.84 |
10,249,672.41 |
| 应付管理人报酬 |
37,223.84 |
38,351.52 |
20,006.22 |
17,244.38 |
| 应付托管费 |
11,167.14 |
11,505.45 |
6,001.89 |
5,173.31 |
| 应付销售服务费 |
260,160.69 |
334,127.87 |
180,687.30 |
118,169.71 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
913.25 |
24,817.53 |
334,715.82 |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
189,768.97 |
175,000.00 |
81,822.86 |
157,023.57 |
| 负债合计 |
42,442,972.62 |
86,164,185.70 |
65,916,095.93 |
11,921,435.54 |
| 所有者权益 |
| 实收基金 |
1,422,133,252.03 |
1,485,006,401.79 |
1,071,286,582.63 |
835,013,299.86 |
| 未分配利润 |
-55,220,006.04 |
178,825,511.60 |
75,520,550.48 |
-233,767,334.71 |
| 所有者权益合计 |
1,366,913,245.99 |
1,663,831,913.39 |
1,146,807,133.11 |
601,245,965.15 |
| 负债及所有者权益总计 |
1,409,356,218.61 |
1,749,996,099.09 |
1,212,723,229.04 |
613,167,400.69 |
微信公众号
证券之星APP
基本资料
